KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Divestments (2020 - 2025)

Pfizer (PFE) has disclosed Divestments for 6 consecutive years, with -$6.3 billion as the latest value for Q3 2025.

  • Quarterly Divestments fell 280.15% to -$6.3 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $6.3 billion for FY2025, 10.36% down from the prior year.
  • Divestments for Q3 2025 was -$6.3 billion at Pfizer, down from $6.3 billion in the prior quarter.
  • The five-year high for Divestments was $6.3 billion in Q1 2025, with the low at -$6.3 billion in Q3 2025.
  • Average Divestments over 4 years is $2.2 billion, with a median of $3.5 billion recorded in 2024.
  • The sharpest move saw Divestments skyrocketed 49600.0% in 2022, then plummeted 280.15% in 2025.
  • Over 4 years, Divestments stood at -$8.0 million in 2021, then surged by 49600.0% to $4.0 billion in 2022, then fell by 11.84% to $3.5 billion in 2024, then tumbled by 280.15% to -$6.3 billion in 2025.
  • According to Business Quant data, Divestments over the past three periods came in at -$6.3 billion, $6.3 billion, and $6.3 billion for Q3 2025, Q2 2025, and Q1 2025 respectively.